<![CDATA[Theramex 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=37156>Mon, 27 Apr 2026 18:01:18 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.]]>https://www.newswire.co.kr/newsRead.php?no=975984Wed, 11 Oct 2023 08:58:26 +0900<![CDATA[Theramex Reinforces its Commitment to Women on International Women’s Day]]>https://www.newswire.co.kr/newsRead.php?no=939267Wed, 09 Feb 2022 16:15:00 +0900<![CDATA[테라멕스, ‘세계 여성의 날’ 맞아 여성 위한 헌신 강화]]>https://www.newswire.co.kr/newsRead.php?no=939268Wed, 09 Feb 2022 16:15:00 +0900<![CDATA[Theramex Enters OTC Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms]]>https://www.newswire.co.kr/newsRead.php?no=934490Tue, 16 Nov 2021 13:15:00 +0900<![CDATA[테라멕스, 비호르몬 폐경기 증상 치료제 페마렐 출시로 OTC 시장 진출]]>https://www.newswire.co.kr/newsRead.php?no=934491Tue, 16 Nov 2021 13:15:00 +0900<![CDATA[Theramex Appoints Sigurd Kirk to the Board of Directors]]>https://www.newswire.co.kr/newsRead.php?no=926972Tue, 13 Jul 2021 09:45:00 +0900<![CDATA[Theramex Launches New Website]]>https://www.newswire.co.kr/newsRead.php?no=919319Wed, 03 Mar 2021 08:50:00 +0900<![CDATA[테라멕스, 새 웹사이트 출범]]>https://www.newswire.co.kr/newsRead.php?no=919320Wed, 03 Mar 2021 08:50:00 +0900